SARS News and Research

RSS

Scientists identify compound that shows potential in easing the symptoms of coronavirus infections

By studying a disease caused by a close cousin of the virus behind COVID-19, a team of scientists has identified a compound that shows potential in easing the symptoms of coronavirus infections.

1 Nov 2021

Study reassures the safety, immunogenicity of COVID-19 vaccines for patients with rheumatic diseases

New research presented this week at ACR Convergence, the American College of Rheumatology's annual meeting, shows that the COVID-19 vaccine was not associated with severe disease flares in patients with rheumatic diseases.

1 Nov 2021

Rice introduces new online portal to help researchers screen COVID-19 drug candidates

Rice University researchers have introduced an online portal to help researchers screen COVID-19 drug candidates that might attack specific proteins of the SARS-CoV-2 virus.

1 Nov 2021

Transmission of COVID-19 from pet parent to pet documented for first time in the U.S.

For the first time in the U.S., the transmission of COVID-19 from pet parent to pet is documented genetically as part of a study by the Translational Genomics Research Institute (TGen), an affiliate of City of Hope.

1 Nov 2021

Curious case of SARS-CoV-2 Delta variant in a dog

In a recent study, researchers document the detection and sequencing of an AY.3 virus from a 12-year-old Collie living with a SARS-CoV-2-infected owner.

1 Nov 2021

New Australian study identifies key barriers to COVID-19 testing and vaccination

A new study aimed to bridge the gap in a culturally and linguistically diverse population concerning COVID-19 testing intentions and vaccine willingness.

1 Nov 2021

New genetic epidemiology tool provides detailed information about viruses, coinfections

With mask wearing and social distancing on the decline and the cold and flu season upon us, researchers have developed a viral panel that enables the simultaneous testing for SARS-CoV-2 along with numerous common respiratory viruses, that tells us whether other viruses also are at play in patients hard hit by COVID.

1 Nov 2021

Evidence antibodies targeting HCoV-OC43 are robustly boosted in response to SARS-CoV-2 but not vaccination

The magnitude of cross-reactive antibodies correlated well with responses to the SARS-CoV-2 spike protein and the S2 subdomain.

1 Nov 2021

Do weather and climate determine where COVID-19 occurs?

A new study provides information on the associations between weather parameters and seasonal coronavirus cases.

1 Nov 2021

SARS-CoV-2 antibodies persisting for nearly a year, including to delta: NZ study

A cohort study found that antibodies to the SARS-CoV-2 spike protein and neutralizing antibodies remain relatively stable 8-11 months post-infection.

1 Nov 2021

Investigation of Budesonide's mechanism of action against SARS-CoV-2

Researchers look to gain an understanding of the mechanism of action of budesonide in improving the prognosis of patients with SARS-CoV-2 infection.

1 Nov 2021

COVID-19 antibody levels stay more durable in vaccinated people with prior SARS-CoV-2 infection

In what is believed to be one of the largest studies of its kind, Johns Hopkins Medicine researchers have shown that antibody levels against SARS-CoV-2 (the COVID-19 virus) stay more durable — that is, remain higher over an extended period of time — in people who were infected by the virus and then received protection from two doses of messenger RNA (mRNA) vaccine compared with those who only got immunized.

1 Nov 2021

SARS News and Research

Scientists identify compound that shows potential in easing the symptoms of coronavirus infections

Study reassures the safety, immunogenicity of COVID-19 vaccines for patients with rheumatic diseases

Rice introduces new online portal to help researchers screen COVID-19 drug candidates

Transmission of COVID-19 from pet parent to pet documented for first time in the U.S.

Curious case of SARS-CoV-2 Delta variant in a dog

New Australian study identifies key barriers to COVID-19 testing and vaccination

New genetic epidemiology tool provides detailed information about viruses, coinfections

Evidence antibodies targeting HCoV-OC43 are robustly boosted in response to SARS-CoV-2 but not vaccination

Do weather and climate determine where COVID-19 occurs?

SARS-CoV-2 antibodies persisting for nearly a year, including to delta: NZ study

Investigation of Budesonide's mechanism of action against SARS-CoV-2

COVID-19 antibody levels stay more durable in vaccinated people with prior SARS-CoV-2 infection

Potential link between SARS-CoV-2 infection and secondary occurrence of anti-NMDAR encephalitis

Can COVID-19 spread through water while swimming?

Curcumin, a bioactive component of turmeric, effectively neutralizes SARS-CoV-2 in vitro

SARS-CoV-2 introduction events in Québec, Canada

Identification of novel nanobodies to specifically target SARS-CoV-2 replication protein

BNT162b2 mRNA COVID-19 vaccine effectiveness amongst Italian healthcare workers

Structural and molecular contributions to understanding antibody recognition of pathogenic viruses

Study finds inhaled microspheres reduce SARS-CoV-2 infective effectiveness

Exploring the G:Box and for high-quality imaging

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Latest News